 | • レポートコード：GIR201111746 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、寄生虫感染症治療薬の世界市場を調査対象にし、寄生虫感染症治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ベンズイミダゾール、ピランテル、クエン酸ピペラジン、その他）、用途別分析（蟯虫、無鉤条虫、ヒトカイチュウ、鞭虫トリキウラ、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Neural Analytics, Inc.、HCA Healthcare, Inc.、Mitochon Pharmaceuticals, Inc.、M3 Biotechnology, Inc.、biOasis Technologies, Inc.、Cerevance、Johnson & Johnson、Farmoquimica S/A、Peptilogics、Alzeca Biosciences, Inc. ・メーカー別販売量、売上、市場シェア ・寄生虫感染症治療薬の地域別市場分析 ・寄生虫感染症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・寄生虫感染症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・寄生虫感染症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・寄生虫感染症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・寄生虫感染症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・寄生虫感染症治療薬の種類別市場規模2015-2020：ベンズイミダゾール、ピランテル、クエン酸ピペラジン、その他 ・寄生虫感染症治療薬の用途別市場規模2015-2020：蟯虫、無鉤条虫、ヒトカイチュウ、鞭虫トリキウラ、その他 ・寄生虫感染症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Helminthic Infestations Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Helminthic Infestations Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Helminthic Infestations Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Helminthic Infestations Therapeutics market has been segmented into
Benzimidazole
Pyrantel
Piperazine Citrate
Others
By Application, Helminthic Infestations Therapeutics has been segmented into:
Enterobius vermicularis
Taenia saginata
Ascaris lumbricoides
Trichuris trichiura
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Helminthic Infestations Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Helminthic Infestations Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Helminthic Infestations Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Helminthic Infestations Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Helminthic Infestations Therapeutics Market Share Analysis
Helminthic Infestations Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Helminthic Infestations Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Helminthic Infestations Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Helminthic Infestations Therapeutics are:
Neural Analytics, Inc.
HCA Healthcare, Inc.
Mitochon Pharmaceuticals, Inc.
M3 Biotechnology, Inc.
biOasis Technologies, Inc.
Cerevance
Johnson & Johnson
Farmoquimica S/A
Peptilogics
Alzeca Biosciences, Inc.
Among other players domestic and global, Helminthic Infestations Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Helminthic Infestations Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Helminthic Infestations Therapeutics, with price, sales, revenue and global market share of Helminthic Infestations Therapeutics in 2018 and 2019.
Chapter 3, the Helminthic Infestations Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Helminthic Infestations Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Helminthic Infestations Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Helminthic Infestations Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Helminthic Infestations Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Helminthic Infestations Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Benzimidazole
1.2.3 Pyrantel
1.2.4 Piperazine Citrate
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Helminthic Infestations Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Enterobius vermicularis
1.3.3 Taenia saginata
1.3.4 Ascaris lumbricoides
1.3.5 Trichuris trichiura
1.3.6 Others
1.4 Overview of Global Helminthic Infestations Therapeutics Market
1.4.1 Global Helminthic Infestations Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Neural Analytics, Inc.
2.1.1 Neural Analytics, Inc. Details
2.1.2 Neural Analytics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Neural Analytics, Inc. SWOT Analysis
2.1.4 Neural Analytics, Inc. Product and Services
2.1.5 Neural Analytics, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 HCA Healthcare, Inc.
2.2.1 HCA Healthcare, Inc. Details
2.2.2 HCA Healthcare, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 HCA Healthcare, Inc. SWOT Analysis
2.2.4 HCA Healthcare, Inc. Product and Services
2.2.5 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mitochon Pharmaceuticals, Inc.
2.3.1 Mitochon Pharmaceuticals, Inc. Details
2.3.2 Mitochon Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mitochon Pharmaceuticals, Inc. SWOT Analysis
2.3.4 Mitochon Pharmaceuticals, Inc. Product and Services
2.3.5 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 M3 Biotechnology, Inc.
2.4.1 M3 Biotechnology, Inc. Details
2.4.2 M3 Biotechnology, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 M3 Biotechnology, Inc. SWOT Analysis
2.4.4 M3 Biotechnology, Inc. Product and Services
2.4.5 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 biOasis Technologies, Inc.
2.5.1 biOasis Technologies, Inc. Details
2.5.2 biOasis Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 biOasis Technologies, Inc. SWOT Analysis
2.5.4 biOasis Technologies, Inc. Product and Services
2.5.5 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cerevance
2.6.1 Cerevance Details
2.6.2 Cerevance Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cerevance SWOT Analysis
2.6.4 Cerevance Product and Services
2.6.5 Cerevance Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Farmoquimica S/A
2.8.1 Farmoquimica S/A Details
2.8.2 Farmoquimica S/A Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Farmoquimica S/A SWOT Analysis
2.8.4 Farmoquimica S/A Product and Services
2.8.5 Farmoquimica S/A Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Peptilogics
2.9.1 Peptilogics Details
2.9.2 Peptilogics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Peptilogics SWOT Analysis
2.9.4 Peptilogics Product and Services
2.9.5 Peptilogics Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Alzeca Biosciences, Inc.
2.10.1 Alzeca Biosciences, Inc. Details
2.10.2 Alzeca Biosciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Alzeca Biosciences, Inc. SWOT Analysis
2.10.4 Alzeca Biosciences, Inc. Product and Services
2.10.5 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Helminthic Infestations Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Helminthic Infestations Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Helminthic Infestations Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 Helminthic Infestations Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Helminthic Infestations Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Helminthic Infestations Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Helminthic Infestations Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Helminthic Infestations Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Helminthic Infestations Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America Helminthic Infestations Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Helminthic Infestations Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Helminthic Infestations Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Helminthic Infestations Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
6.4 France Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Helminthic Infestations Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Helminthic Infestations Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
7.5 India Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Helminthic Infestations Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Helminthic Infestations Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America Helminthic Infestations Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Helminthic Infestations Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Helminthic Infestations Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Helminthic Infestations Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Helminthic Infestations Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global Helminthic Infestations Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global Helminthic Infestations Therapeutics Price by Type (2015-2020)
11 Global Helminthic Infestations Therapeutics Market Segment by Application
11.1 Global Helminthic Infestations Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global Helminthic Infestations Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 Helminthic Infestations Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America Helminthic Infestations Therapeutics Market Forecast (2021-2025)
12.2.2 Europe Helminthic Infestations Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Helminthic Infestations Therapeutics Market Forecast (2021-2025)
12.2.4 South America Helminthic Infestations Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Helminthic Infestations Therapeutics Market Forecast (2021-2025)
12.3 Helminthic Infestations Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global Helminthic Infestations Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global Helminthic Infestations Therapeutics Market Share Forecast by Type (2021-2025)
12.4 Helminthic Infestations Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global Helminthic Infestations Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global Helminthic Infestations Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Helminthic Infestations Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Neural Analytics, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Neural Analytics, Inc. Helminthic Infestations Therapeutics Major Business
Table 9. Neural Analytics, Inc. Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 10. Neural Analytics, Inc. SWOT Analysis
Table 11. Neural Analytics, Inc. Helminthic Infestations Therapeutics Product and Services
Table 12. Neural Analytics, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. HCA Healthcare, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Major Business
Table 15. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 16. HCA Healthcare, Inc. SWOT Analysis
Table 17. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product and Services
Table 18. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Mitochon Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Major Business
Table 21. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 22. Mitochon Pharmaceuticals, Inc. SWOT Analysis
Table 23. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product and Services
Table 24. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. M3 Biotechnology, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Major Business
Table 27. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 28. M3 Biotechnology, Inc. SWOT Analysis
Table 29. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product and Services
Table 30. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. biOasis Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Major Business
Table 33. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 34. biOasis Technologies, Inc. SWOT Analysis
Table 35. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product and Services
Table 36. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Cerevance Basic Information, Manufacturing Base and Competitors
Table 38. Cerevance Helminthic Infestations Therapeutics Major Business
Table 39. Cerevance Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 40. Cerevance SWOT Analysis
Table 41. Cerevance Helminthic Infestations Therapeutics Product and Services
Table 42. Cerevance Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Helminthic Infestations Therapeutics Major Business
Table 45. Johnson & Johnson Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 46. Johnson & Johnson SWOT Analysis
Table 47. Johnson & Johnson Helminthic Infestations Therapeutics Product and Services
Table 48. Johnson & Johnson Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Farmoquimica S/A Basic Information, Manufacturing Base and Competitors
Table 50. Farmoquimica S/A Helminthic Infestations Therapeutics Major Business
Table 51. Farmoquimica S/A Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 52. Farmoquimica S/A SWOT Analysis
Table 53. Farmoquimica S/A Helminthic Infestations Therapeutics Product and Services
Table 54. Farmoquimica S/A Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Peptilogics Basic Information, Manufacturing Base and Competitors
Table 56. Peptilogics Helminthic Infestations Therapeutics Major Business
Table 57. Peptilogics Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 58. Peptilogics SWOT Analysis
Table 59. Peptilogics Helminthic Infestations Therapeutics Product and Services
Table 60. Peptilogics Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Alzeca Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Major Business
Table 63. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Total Revenue (USD Million) (2018-2019)
Table 64. Alzeca Biosciences, Inc. SWOT Analysis
Table 65. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product and Services
Table 66. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Helminthic Infestations Therapeutics Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Helminthic Infestations Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Helminthic Infestations Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Helminthic Infestations Therapeutics Sales Market Share by Regions (2015-2020)
Table 71. Global Helminthic Infestations Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Helminthic Infestations Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Helminthic Infestations Therapeutics Sales Market Share by Countries (2015-2020)
Table 74. North America Helminthic Infestations Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Helminthic Infestations Therapeutics Revenue Market Share by Countries (2015-2020)
Table 76. Europe Helminthic Infestations Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Helminthic Infestations Therapeutics Sales Market Share by Countries (2015-2020)
Table 78. Europe Helminthic Infestations Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Helminthic Infestations Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Helminthic Infestations Therapeutics Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Helminthic Infestations Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Helminthic Infestations Therapeutics Sales Market Share by Countries (2015-2020)
Table 84. South America Helminthic Infestations Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Helminthic Infestations Therapeutics Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Helminthic Infestations Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Helminthic Infestations Therapeutics Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Helminthic Infestations Therapeutics Revenue Market Share by Countries (2015-2020)
Table 90. Global Helminthic Infestations Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 91. Global Helminthic Infestations Therapeutics Sales Share by Type (2015-2020)
Table 92. Global Helminthic Infestations Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 93. Global Helminthic Infestations Therapeutics Revenue Share by Type (2015-2020)
Table 94. Global Helminthic Infestations Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 95. Global Helminthic Infestations Therapeutics Sales Share by Application (2015-2020)
Table 96. Global Helminthic Infestations Therapeutics Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Helminthic Infestations Therapeutics Market Share Forecast by Regions (2021-2025)
Table 98. Global Helminthic Infestations Therapeutics Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Helminthic Infestations Therapeutics Market Share Forecast by Type (2021-2025)
Table 100. Global Helminthic Infestations Therapeutics Sales Forecast by Application (2021-2025)
Table 101. Global Helminthic Infestations Therapeutics Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Helminthic Infestations Therapeutics Picture
Figure 2. Global Sales Market Share of Helminthic Infestations Therapeutics by Type in 2019
Figure 3. Benzimidazole Picture
Figure 4. Pyrantel Picture
Figure 5. Piperazine Citrate Picture
Figure 6. Others Picture
Figure 7. Helminthic Infestations Therapeutics Sales Market Share by Application in 2018
Figure 8. Enterobius vermicularis Picture
Figure 9. Taenia saginata Picture
Figure 10. Ascaris lumbricoides Picture
Figure 11. Trichuris trichiura Picture
Figure 12. Others Picture
Figure 13. Global Helminthic Infestations Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Helminthic Infestations Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Helminthic Infestations Therapeutics Sales Market Share by Manufacturer in 2019
Figure 34. Global Helminthic Infestations Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Helminthic Infestations Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Helminthic Infestations Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Helminthic Infestations Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Helminthic Infestations Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 41. Global Helminthic Infestations Therapeutics Revenue Market Share by Regions in 2018
Figure 42. North America Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
Figure 43. Europe Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
Figure 45. South America Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020)
Figure 47. North America Helminthic Infestations Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Helminthic Infestations Therapeutics Sales Market Share by Countries (2015-2020)
Figure 49. North America Helminthic Infestations Therapeutics Sales Market Share by Countries in 2018
Figure 50. North America Helminthic Infestations Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Helminthic Infestations Therapeutics Revenue Market Share by Countries in 2018
Figure 52. United States Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Helminthic Infestations Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Helminthic Infestations Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Helminthic Infestations Therapeutics Revenue Market Share by Countries in 2019
Figure 58. Germany Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Helminthic Infestations Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Helminthic Infestations Therapeutics Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Helminthic Infestations Therapeutics Revenue Market Share by Regions 2019
Figure 66. China Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Helminthic Infestations Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Helminthic Infestations Therapeutics Sales Market Share by Countries in 2019
Figure 73. South America Helminthic Infestations Therapeutics Revenue Market Share by Countries in 2019
Figure 74. Brazil Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Helminthic Infestations Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Helminthic Infestations Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Helminthic Infestations Therapeutics Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Helminthic Infestations Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Helminthic Infestations Therapeutics Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Helminthic Infestations Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Helminthic Infestations Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Helminthic Infestations Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Helminthic Infestations Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Helminthic Infestations Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Helminthic Infestations Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
カナバン病治療薬の世界市場 2020年 Market Overview The global Canavan Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canavan Disease …- 増殖性硝子体網膜症（PVR）治療の世界市場 2020年 Market Overview The global Proliferative Vitreoretinopathy (PVR) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019…
- 子宮頸部ジストニア治療の世界市場 2020年 Market Overview The global Cervical Dystonia Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cervical Dysto…
- 糖鎖生物学（診断及び治療）の世界市場 2020年 Market Overview The global Glycobiology (Diagnostics and Therapeutics) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The G…
- 抗体療法及び血液抗体療法の世界市場 2020年 Market Overview The Antibody Therapeutics and Blood Antibody Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pl…